Introduction
Protein tyrosine kinases are important components of signaling pathways that control growth, dierentiation and apoptosis. Related Adhesion Focal Tyrosine Kinase (RAFTK), also known as Proline-Rich Tyrosine Kinase 2 (Pyk2), Calcium-Dependent Tyrosine Kinase (CADTK), and Cellular Adhesion Kinase b (CAKb), is a recently described cytoplasmic tyrosine kinase that is homologous to Focal Adhesion Kinase (FAK) (Lev et al., 1995; Avraham et al., 1995; Sasaki et al., 1995; Avraham and Avraham, 1997) . RAFTK is rapidly phosphorylated on tyrosine residues in response to various stimuli, including elevated intracellular calcium levels, activated PKC, stress factors (e.g., UV light and TNFa), ATP, activation of angiotensin II receptor, T cell receptor engagement, and a-1 integrin stimulation in B cells (Lev et al., 1995; Tokiwa et al., 1996; Yu et al., 1996; Swanson et al., 1998; Berg and Ostergaard, 1997; Astier et al., 1997a) . RAFTK interacts with several proteins involved in integrin signaling, including paxillin and Src kinases (Tokiwa et al., 1996; Salgia et al., 1996; Dikic et al., 1998) . Other studies have demonstrated that RAFTK dierentially phosphorylates docking molecules, substrates such as p130 cas and p105 HEF mediating downstream signaling (Astier et al., 1997b) . More recent work has shown that RAFTK regulates stress-induced c-Jun N-terminal protein kinase (JNK) and Mitogen-Activated Protein (MAP) kinase activation in PC12 neuronal cell (Lev et al., 1995; Tokiwa et al., 1996) . In addition, overexpression of wild type RAFTK in both ®broblastic and epithelial cell lines leads to apoptosis (Xiong and Parsons, 1997) . The N-terminal domain and tyrosine kinase activity of RAFTK is required for its apoptotic activity (Xiong and Parsons, 1997) .
The cellular response to Dexamethasone (Dex) includes growth arrest and induction of apoptosis (Chauhan et al., 1997a) ; however, the molecular mechanisms that control these events remain elusive. Our previous studies have demonstrated that apoptosis of multiple myeloma (MM) cells induced in response to anti-Fas mAb or irradiation (IR), but not that induced by Dex, is associated with activation of JNK and p38 MAP kinases (Chauhan et al., 1997a,b) . Moreover, in contrast to Dex, IR-induced apoptosis is also associated with the release of mitochondrial cytochrome c into the cytosol (Chauhan et al., 1997c) . Taken together, these ®ndings indicated that there are at least two distinct signaling pathways that control apoptosis in MM cells.
The results of the present study demonstrate that Dex triggers both RAFTK activation and apoptosis in Dex-sensitive MM and myeloid leukemic cells, but not in Dex-resistant MM cells. Dex did not induce tyrosine phosphorylation of FAK. Transient overexpression of RAFTK wild type (RAFTK WT) induces apoptosis, whereas overexpression of the RAFTK kinase inactive mutant (RAFTK K-M) inhibits Dex-induced apopto-sis. In contrast, IR and anti-Fas mAb-induced apoptosis was neither associated with RAFTK activation nor blocked by overexpression of RAFTK K-M. Finally, pretreatment of MM cells with IL-6, a known growth and survival factor for MM cells (Hardin et al., 1994; Klein et al., 1995) , signi®cantly inhibits both activation of RAFTK and apoptosis triggered by Dex. Taken together, these results demonstrate two dierent apoptotic pathways in MM cells: one induced by Dex and mediated by RAFTK; and another triggered by IR or anti-Fas mAb or UV, which is independent of RAFTK.
Results and discussion
Previous studies have demonstrated that certain agents, such as hyperosmolarity, sorbitol, phorbol myristate acetate, and stem cell factor, activate RAFTK (Avraham et al., 1995; Hiregowdara et al., 1997; Yu et al., 1996; Derkinderen et al., 1998) . RAFTK has been linked to cell-type speci®c activation of JNK and MAPK signaling pathways (Lev et al., 1995; Tokiwa et al., 1996) . In addition, recent studies have demonstrated that overexpression of RAFTK in mouse ®broblasts leads to apoptosis (Xiong and Parsons, 1997) . However, to date the in vivo functional role of RAFTK remains largely unknown.
We have previously demonstrated that treatment of MM.1S cells with Dex or IR triggers apoptosis, and that IR, but not Dex, triggers activation of c-Jun amino-terminal kinases (JNK) and p38 mitogen activated protein kinase (MAPK) (Chauhan et al., 1997a,b,c) . In the present study, we determined whether RAFTK is activated during apotosis induced by these stimuli. To determine whether RAFTK is activated in response to Dex, lysates from control and Dex-treated MM.1S cells were subjected to immunoprecipitation with anti-RAFTK Ab and analysed by immunoblotting with anti-P-Tyr Ab. Treatment of cells with Dex leads to tyrosine phosphorylation of RAFTK at 3 h and 6 h that reached maximum levels (®vefold increase) at 12 h ( Figure 1a, upper panel) . This increase in tyrosine phosphorylation of RAFTK was not associated with any signi®cant changes in RAFTK protein levels (Figure 1a, lower panel) . In order to determine if another member of the focal adhesion tyrosine kinase (FAK) family with homology to RAFTK is also activated during Dex-induced apoptosis, lysates from Dex-treated cells were subjected to immunoprecipitation with anti-FAK Ab and analysed by immunoblotting with anti-p-Tyr Ab. No tyrosine phosphorylation of FAK was induced in response to Dex treatment (Figure 1b, upper panel) ; reprobing of the ®lter membrane demonstrated no alterations in FAK protein levels ( Figure 1b , lower panel). The ®nding that Dex activates RAFTK, but not FAK, is in concert a recent report that ligation of CD28 in Jurkat T cells induces tyrosine phosphorylation of RAFTK, but not FAK (Tsuchida et al., 1999) . Moreover, previous studies also suggest that RAFTK and FAK, although similar in structure, may have distinct functions; i.e., FAK is required for survival whereas RAFTK induces apoptosis in rat and mouse ®broblasts (Xiong and Parsons, 1997) .
Diverse stress factors, including ultraviolet irradiation (UV) and tumor necrosis factor (TNF-a) induce RAFTK tyrosine phosphorylation (Lev et al., 1995;  Tokiwa et al., 1996) . Our recent study demonstrated that RAFTK is also activated by methylmethane sulfonate (MMS), but not by UV, cis-platinum or IR . In the present study we next examined the eect of other apoptotic agents including UV, IR or anti-Fas mAb, on RAFTK activation in MM.1S cells at 15 min, 30 min, 1, 3, 6 and 12 h. Lysates from control and Dex-treated MM.1S cells were subjected to immunoprecipitation with anti-RAFTK Ab and analysed by immunoblotting with anti-P-Tyr Ab. In contrast to Dex, the other stimuli (UV, IR and anti-Fas mAb) do not induce tyrosine phosphorylation of RAFTK (Figure 1c ± e) or changes in RAFTK protein levels (Figure 1c ± e). These ®ndings, coupled with prior reports (Lev et al., 1995; Tokiwa et al., 1996; , therefore suggest that kinetics of RAFTK activation may relate to speci®c cell type or stress stimuli.
RAFTK autophosphorylates on Tyr402 (Tokiwa et al., 1996) , which is important for tyrosine kinase activity (Li et al., 1999) . Moreover, recent studies have demonstrated that p105HEF protein acts as a substrate for RAFTK both in vitro and in vivo (Astier et al., 1997b) . To demonstrate that Dex-triggers RAFTK activation, we assayed for RAFTK autophosphorylation and its ability to phosphorylate GST-HEF in response to Dex. Treatment of MM. Previous studies have shown that overexpression of RAFTK in rat and mouse ®broblasts leads to apoptotic cell death (Xiong and Parsons, 1997) . Tyr 402 in the NH2-terminal of RAFTK is a major tyrosine autophosphorylation site, and mutation at this site (RAFTK Y402F) inhibits both RAFTK tyrosine autophosphorylation and related tyrosine kinase activity. Mutation of the RAFTK Mg 2+ -ATP-binding site (K457M/RAFTK K-M) inhibits tyrosine kinase activity and has a dominant negative aect (Li et al., 1999) . To determine whether RAFTK tyrosine kinase activity is required for induction of apoptosis in response to Dex, we next transiently transfected MM.1S cells with wild type RAFTK (RAFTK-WT), RAFTK Y402F, and RAFTK K-M. In each case cells were cotransfected with construct containing Green Fluorescence Protein (GFP) alone. GFP positive cells were then selected, treated with Dex, and assayed for apoptosis. As measures of apoptosis, we utilized DNA fragmentation assays (for oligonucleosomal fragments), propidium iodide (PI) staining (for cells in the sub-G1 fractions) and Hoechst 33342 (HO 33342) staining (for apoptotic nuclei) (Hamel et al., 1996; Hardin et al., 1992) . The percentage of apoptotic cells (HO + PI 7 ) was determined using dual¯uorescence¯ow cytometry (Hamel et al., 1996; Hardin et al., 1992) . MM.1S cells overexpressing GFP vector alone were also treated with Dex as a control. Transient overexpression of RAFTK-WT induces signi®cant apoptosis in non Dex treated cells compared to cells transfected with control vector alone, as evidenced both by increased DNA fragmentation (Figure 3a) and percentage of HO + PI 7 apoptotic cells (Figure 3b ). Transient overexpression of RAFTK K-M signi®cantly inhibited Dex-induced DNA fragmentation (Figure 3a) and decreased the percentage of apoptotic cells (Figure 3b ), compared both to Dex-treated control vector cells and to RAFTK WT cells which were either treated or not treated with Dex (Figure 3a) . These ®ndings suggest that RAFTK kinase activity is required for induction of apoptosis in response to Dex. We next determined whether mutations in the RAFTK autophosphorylation site Y402F aects Dex-induced RAFTK kinase activity and apoptosis. Transient overexpression of RAFTK-Y402F also results in apoptosis in non-Dex treated cells, but less apoptosis than is observed in RAFTK WT cells (Figure 3a, b) . This ®nding is consistent with reports suggesting that mutation in the autophosphorylation site Y402 leads to a reduction in RAFTK kinase activity and apoptosis (Xiong and Parsons, 1997; Li et al., 1999) . However, Dex triggered apoptosis in RAFTK Y402F transfected cells ( Figure  3a,b) , indicating that endogenous RAFTK is inducible in response to Dex since RAFTK Y402F is catalytically less active than RAFTK WT but does not function as a dominant negative. The observation that overexpression of RAFTK induces apoptosis, coupled with the ®nding that blocking Dex-induced RAFTK kinase activity inhibits apoptosis, strongly supports the role of RAFTK in apoptotic signaling triggered by Dex.
We next determined whether transient overexpression of RAFTK K-M also blocks apoptosis triggered by IR or anti-Fas mAb. MM.1S cells were transiently transfected with vector containing GFP alone or with GFP-tagged RAFTK K-M. Cells were selected, treated with Dex, harvested, and assayed for apoptosis. As shown in Figure 4a Having shown that RAFTK activation was required for induction of apoptosis of MM.1S cells induced by Dex, we next examined whether lack of RAFTK activation in MM cells may correlate with resistance to Dex. We studied the eect of Dex on RAFTK tyrosine phosphorylation in Dex-resistant MM.1R cells, derived from parental Dex-sensitive MM.1S cells. As seen in Figure 5a , Dex does not induce DNA fragmentation in MM.1R cells. To assay for RAFTK activation, MM.1R cells were treated with Dex and total cell lysates immunoprecipitated with anti-RAFTK Ab, followed by immunoblotting with anti-P-Tyr Ab. Treatment of MM.1R cells with Dex is not associated with an increase in tyrosine phosphorylation of RAFTK (Figure 5b, upper panel) or change in RAFTK protein levels (Figure 5b, lower panel) . To further examine whether resistance to Dex is due to lack of RAFTK activity in other Dex-resistant cells, we assayed for RAFTK tyrosine phosphorylation in Dexresistant U266, IM9, and HS Sultan MM cells in response to Dex treatment. As a positive control, we included another Dex-sensitive MM cell line (OCI-MY5). No detectable increase in RAFTK tyrosine phosphorylation was observed in Dex-treated U266, IM9 or HS Sultan cells (Figure 5c ), whereas Dex induced a fourfold increase in RAFTK tyrosine phosphorylation in OCI-MY5 cells (Figure 5d , upper panel) without changes in RAFTK protein levels (Figure 5d, lower panel) . Taken together, these ®ndings suggest that lack of RAFTK activation by Dex confers resistance to Dex-induced apoptosis.
Previous studies have shown that pretreatment of MM cells with IL-6 inhibits apoptosis induced in response to Dex (Hardin et al., 1994; Chauhan et al., 1997a,c; Xu et al., 1998) . In the present study, we therefore next examined whether IL-6 mediates resistance to Dex via RAFTK. MM.1S cells were treated with Dex in the presence and absence of IL-6, and anti-RAFTK immunoprecipitates assayed by immunoblotting with anti-P-Tyr Ab. Treatment of cells with IL-6 alone at various time intervals has no detectable eect on activation of RAFTK, whereas Dex alone (used as a positive control) induced RAFTK tyrosine phosphorylation (Figure 6a, upper panel) . Reprobing of the ®lters demonstrated no change in RAFTK protein levels (Figure 6a, lower panel) . Importantly, Dex-induced RAFTK activity and apoptosis was completely inhibited in MM.1S cells pretreated with IL-6 (Figure 6b and data not shown) . By contrast, IL-6 had no detectable eect on IRinduced apoptosis in MM.1S cells (data not shown). The observations that either pretreatment with IL-6 or overexpression of RAFTK K-M in MM.1S cells prevents Dex-induced RAFTK activation and apopto- sis, coupled with the lack of RAFTK activation and apoptosis in response to Dex in MM.1R (Dexresistant) cells, con®rms the role of RAFTK in mediating Dex-induced apoptosis. Moreover, it is consistent with the known resistance to Dex-treatment in MM patients with advanced disease and high serum levels of IL-6 (Klein et al., 1995) . It further suggests that potential therapeutic strategies which bypass this blockade in RAFTK activation may overcome Dex resistance.
Apoptosis triggered by diverse agents have been associated with activation of JNK and p38 MAP kinases (Verheij et al., 1996; Xia et al., 1995) . However, apoptotic signaling via JNK and/or p38 MAP kinase is not always associated with activation of RAFTK. Our recent study showed that MMS, an alkylating agent, induces RAFTK and p38 MAP kinase activation, in contrast to other stimuli (IR, UV or cis-platinum), which induce p38 MAP kinase, but not RAFTK, activation . Sorbitol and NaCl activate both JNK and RAFTK, whereas other stimuli (UV, anisomycin, and TNFa , activate JNK, but not RAFTK (Li et al., 1999) . Our prior (Chauhan et al., 1997a,b,c) and present studies demonstrate that IR and anti-Fas mAb, but not Dex, activate JNK and p38 MAPK; conversely Dex, but not IR, anti-Fas, or UV activates RAFTK. Furthermore, the results of the present study demonstrate that Dex-induced apoptosis, in contrast to IR, anti-Fas mAb, or UV, is mediated by RAFTK. Finally, in contrast to these studies, UV treatment has been reported to activate RAFTK in PC12 cells (Tokiwa et al., 1996) . It therefore appears that distinct stress factors activate JNK, p38 MAPK, and/or RAFTK, with an additional level of complexity since a given stimulus can also have distinct eects depending upon the lineage of the target cell.
Finally, activation of proteases/caspases plays an important role during apoptosis (Thornberry et al., 1997) , and blockade of Ice-like protease activation inhibits apoptosis; i.e. overexpression of the ICE inhibitor CrmA, but not Bcl-2, inhibits RAFTKmediated apoptosis (Xiong et al., 1997) . Our recent study demonstrates that Bcl-x l , in contrast to CrmA or p35, blocks MMS-triggered RAFTK-JNK activation . It suggests that RAFTK-JNK pathway is an upstream event to caspase activation. Our prior studies in MM cells demonstrated that Dexinduced apoptosis is associated with activation of cysteine proteases (CPP32/Yama/apopain) (Chauhan et al., 1997a) . To determine whether Dex-induced apoptosis and RAFTK activation is aected by inhibition of caspases, we used Z-VAD-FMK, a highly speci®c and irreversible inhibitor of caspases including caspase 1. The percentage of apoptotic cells after Dex treatment was signi®cantly (P50.05, n=3) reduced in the presence of Z-VAD-FMK (12.7+1.3%) versus media alone (41.2+2.5%). Moreover, Z-VAD-FMK does not block Dex-induced RAFTK activation, further suggesting that RAFTK is upstream to caspase activation in the Dex-induced apoptotic signaling cascade.
In conclusion, the results of the present study demonstrate that (1) Dex-induced apoptosis, in contrast to apoptosis triggered by IR, anti-Fas mAb, or UV, is mediated by RAFTK; (2) RAFTK tyrosine kinase activity is required for Dex-induced apoptosis; (3) lack of RAFTK activation may confer Dexresistance; and ®nally, (4) IL-6 inhibits both Dexinduced RAFTK tyrosine kinase activity and apoptosis. These ®ndings provide the ®rst evidence of a direct role for RAFTK in mediating apoptosis in vivo and may suggest novel therapeutic strategies based upon targeting RAFTK in MM cells.
Materials and methods

Cell culture and reagents
Human MM.1S (Dex-sensitive) and MM.1R (Dex-resistant) MM cells were grown in RPMI-1640 media supplemented with 10% heat inactivated fetal-bovine serum (HI-FBS), 100 units/ml penicillin, 100 mg/ml streptomycin, and 2 mM Lglutamine. Dex-sensitive MM (RPMI-8226, OCI-MY5) and leukemia (U937) as well as Dex-resistant MM (U266, IM9, HS Sultan) cell lines were cultured in media, as described above. Cells were either treated with 10 mM Dex (Sigma); anti-Fas mAb (7C11); or 20 Gy g-irradiation (IR) at room temperature using a Gamma-cell 1000 (Atomic Energy of Canada, Ottawa, Canada) under aerobic conditions with a
137
Cs source emitting at a ®xed dose rate of 0.76 Gy min 
Immunoprecipitation and immunoblot analysis
Cells were washed with PBS and lysed in 1 ml of lysis buer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% NP-40, 1 mM sodium vanadate, 1 mM PMSF, 1 mM DTT and 10 mg/ml of leupeptin and aprotinin) as described (Chauhan et al., 1995) . Lysates were incubated with anti-RAFTK (Avraham and Avraham, 1997) or anti-FAK (Transduction Labs) Abs for 1 h at 48C, and then for 45 min after the addition of protein G-Sepharose. Immune complexes were analysed by immunoblotting with anti-P-Tyr (RC20, Transduction Laboratories, Lexington, KY, USA), anti-RAFTK, or anti-FAK Abs. Proteins were separated by electrophoresis in 7.5% SDS ± PAGE gels, transferred to nitrocellulose paper, and analysed by immunoblot analysis. The antigen-antibody complexes were visualized by chemiluminescence (ECL, Amersham).
RAFTK autophosphorylation and immune complex kinase assays
Cells were treated with 10 mM Dex, anti-Fas mAb, or IR and harvested at dierent time intervals. Cell lysates were prepared in 1 ml of lysis buer and incubated with anti-RAFTK Ab (as described above). Immune complexes were washed three times with lysis buer, once with kinase buer (20 mM HEPES, pH 7.6, 10 mM MgCl 2 , 10 mM MnCl 2 , 1 mM DTT), and then resuspended in kinase buer containing [g-32 P]ATP (6000 Ci/mmol; NEN Life Science Products, Boston, MA, USA) with or without GST-HEF (82 ± 398). The reactions were incubated for 30 min at 308C. Proteins were separated by 10% SDS ± PAGE, and analysed by autoradiography. Immune complexes were also analysed by immunoblotting with anti-RAFTK or anti-P-Tyr Abs.
Transient transfections
MM.1S MM cells were transiently transfected with vector containing Green Fluorescence Protein (GFP) alone or with Kinase inactive mutant RAFTK K-M (lysine [K] 457 to Metheonine [M]), using superfect transfection reagent as per manufacturer's instructions (Quiagen, Santa Clarita, CA, USA). Cells were also co-transfected with GFP vector alone or with RAFTK wild type (WT), as well as other mutational constructs of RAFTK: RAFTK Y402F (mutated autophosphorylation site, i.e., tyrosine [Y] to phenylalanine [F] ); and RAFTK K457M/RAFTK K-M (kinase inactive RAFTK). Cells were sorted for the presence of GFP by¯ow cytometry using The MoFlo High Speed Sorter (Cytomation). The GFP sorted cells (95 ± 98% GFP positive) were treated with 10 mM Dex, anti-Fas mAb, or IR; harvested after 24 h; and analysed for apoptosis.
Determination and quanti®cation of apoptosis
Apoptosis was measured by DNA fragmentation assay, a hallmark of apoptosis, and further con®rmed by¯ow cytometric analyses with either Propidium Iodide (PI) staining alone or dual¯uorescence staining with Hoechst (HO) 33342 and PI stains (Hamel et al., 1996; Hardin et al., 1992) .
DNA fragmentation assays
Genomic DNA was isolated from control and treated GFPselected cells, electrophoresed for 2 ± 3 h at 90 V on 1.8% agarose gels containing 5 mg/ml ethidium bromide, and analysed under UV light for DNA fragmentation.
Flow cytometric analyses
DNA content was assessed by staining ethanol-®xed cells with PI, and analysed by¯ow cytometry using the Epics cell sorter (Coulter) as previously described (Chauhan et al., 1997) . The numbers of cells with sub-G 1 DNA content were determined using program M cycle software (Coulter). Dual uorescence color staining with the DNA-Binding fluorochromes HO and PI was used to quantitate the percentage of apoptotic (HO + PI 7 ) cells. Aliquots of cells were treated with HO 33342, followed by the addition of PI stain, and then analysed for HO 33342 and PI expression using dual uorescence¯ow cytometry (`The Vantage', Becton Dickinson), as previously described (Hamel et al., 1996; Hardin et al. 1992) .
